Vascular ATP-sensitive K + channels support maximal aerobic capacity and critical speed via convective and diffusive O 2 transport
Oral sulphonylureas, widely prescribed for diabetes, inhibit pancreatic ATP-sensitive K (K ) channels to increase insulin release. However, K channels are also located within vascular (endothelium and smooth muscle) and muscle (cardiac and skeletal) tissue. We evaluated left ventricular function at...
Gespeichert in:
Veröffentlicht in: | The Journal of physiology 2020-11, Vol.598 (21), p.4843-4858 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Oral sulphonylureas, widely prescribed for diabetes, inhibit pancreatic ATP-sensitive K
(K
) channels to increase insulin release. However, K
channels are also located within vascular (endothelium and smooth muscle) and muscle (cardiac and skeletal) tissue. We evaluated left ventricular function at rest, maximal aerobic capacity (
O
max) and submaximal exercise tolerance (i.e. speed-duration relationship) during treadmill running in rats, before and after systemic K
channel inhibition via glibenclamide. Glibenclamide impaired critical speed proportionally more than
O
max but did not alter resting cardiac output. Vascular K
channel function (topical glibenclamide superfused onto hindlimb skeletal muscle) resolved a decreased blood flow and interstitial PO
during twitch contractions reflecting impaired O
delivery-to-utilization matching. Our findings demonstrate that systemic K
channel inhibition reduces
O
max and critical speed during treadmill running in rats due, in part, to impaired convective and diffusive O
delivery, and thus
O
, especially within fast-twitch oxidative skeletal muscle.
Vascular ATP-sensitive K
(K
) channels support skeletal muscle blood flow and microvascular oxygen delivery-to-utilization matching during exercise. However, oral sulphonylurea treatment for diabetes inhibits pancreatic K
channels to enhance insulin release. Herein we tested the hypotheses that: i) systemic K
channel inhibition via glibenclamide (GLI; 10 mg kg
i.p.) would decrease cardiac output at rest (echocardiography), maximal aerobic capacity (
O
max) and the speed-duration relationship (i.e. lower critical speed (CS)) during treadmill running; and ii) local K
channel inhibition (5 mg kg
GLI superfusion) would decrease blood flow (15 µm microspheres), interstitial space oxygen pressures (PO
is; phosphorescence quenching) and convective and diffusive O
transport (
O
and DO
, respectively; Fick Principle and Law of Diffusion) in contracting fast-twitch oxidative mixed gastrocnemius muscle (MG: 9% type I+IIa fibres). At rest, GLI slowed left ventricular relaxation (2.11 ± 0.59 vs. 1.70 ± 0.23 cm s
) and decreased heart rate (321 ± 23 vs. 304 ± 22 bpm, both P < 0.05) while cardiac output remained unaltered (219 ± 64 vs. 197 ± 39 ml min
, P > 0.05). During exercise, GLI reduced
O
max (71.5 ± 3.1 vs. 67.9 ± 4.8 ml kg
min
) and CS (35.9 ± 2.4 vs. 31.9 ± 3.1 m min
, both P < 0.05). Local K
channel inhibition decreased MG blood flow (52 ± 25 vs. 34 ± 13 ml min
100 g tissue
) |
---|---|
ISSN: | 0022-3751 1469-7793 |
DOI: | 10.1113/JP280232 |